Our Bureau, Mumbai Thursday, January 30, 2025, 17:40 Hrs [IST] ...

Other PBC candidates coming through the collective industry pipeline include CymaBay's seladelpar and Zydus Cadila's saroglitazar - both PPAR agonists – as well as Genkyotex' NOX 1 and 4 ...

Several copycat versions of the drug have already been approved, including from Zydus Cadila and Lupin Labs. However, given Astellas’ plan to elevate the case to the Court of Appeals for the ...

Herpes Labialis Treatment Market. The global herpes labialis treatment market is on track for substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 4.7% from ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...

It was subsequently taken over in June 1991 by Yuhan Group South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd.